Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Parkville, VIC-based Phrenix Therapeutics operates in Biotechnology Research. It is privately held, and its site is twitter.com. It holds one address on record, all in Australia. Headcount on record is 5. Its work is tagged mental health and biotech. One Australian registration (ABN) is a confirmed match. It is listed alongside eight similar brands, mostly in Biotechnology Research.
ABN74659748446
| PHRENIX THERAPEUTICS PTY LTD | ABN 74659748446 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Developing transformative therapeutics for cognitive impairments in schizophrenia
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Victoria entity on the ABR: PHRENIX THERAPEUTICS PTY LTD (ABN 74 659 748 446), high confidence.
5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Parkville, VIC 3052.
None linked to this brand.
Six tags on the brand's own list, among them mental health and biotech.
10 profiles list Phrenix Therapeutics as a peer — 82nd percentile in Biotechnology Research. It lists ten peers of its own. Cincera Therapeutics Pty Ltd and Myostellar list it back.